This article explores the role of reducing immunosuppression as a therapeutic strategy for the problem of transplant-associated skin cancer. The specific issue of immunosuppression reduction is based on a brief historic review of the epidemiology of skin cancer in transplant patients, followed by a description of the role of immunosuppression as a cause of skin cancer. Finally, the literature pertaining to the hypothesis that reducing immunosuppression in solid organ transplant recipients favorably impacts both the incidence of cutaneous malignancy and outcomes relating to individual aggressive malignancies is presented. © Journal of the National Comprehensive Cancer Network.
CITATION STYLE
Neuburg, M. (2007). Transplant-associated skin cancer: Role of reducing immunosuppression. JNCCN Journal of the National Comprehensive Cancer Network. Jones and Bartlett Publishers. https://doi.org/10.6004/jnccn.2007.0047
Mendeley helps you to discover research relevant for your work.